Moderna (MRNA) filed a request for emergency use authorization (EAU) for its COVID-19 vaccine for use in kids between 6 months and under 6 years Thursday.
The request is for the approval of two doses of 25 micrograms of the mRNA vaccine.
Moderna’s clinical data showed the vaccine was 51% effective for the older cohort of the age group, from 2 years to under six years, and 37% effective for the younger group. The company said this is about the same as adult vaccine efficacy of two doses against…
Source link
